Periyasamy Govindaraj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Periyasamy Govindaraj has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
Arun B. Taly
Departments of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India
8 shared publications- Parayil Sankaran Bindu
Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
8 shared publications - Kumarasamy Thangaraj
CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India
6 shared publications Sanjib Sinha
Departments of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India
6 shared publicationsMadhu Nagappa
Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India; Neuromuscular Laboratory, Neurobiology Research Centre, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India
5 shared publications- Madhu Nagappa
Department of Neurology, Neuroscience Faculty Center, National Institute of Mental Health and Neurosciences, Bengaluru, India
5 shared publications
Latest Publications
- 14 April 2026
- Published by Elsevier in Psychiatry Research
- Vol. 361, 117168
Placental mitochondrial DNA variants, copy number and telomere length alterations in relation to antenatal depressive symptoms
- 14 April 2026
- Published by Elsevier in Psychiatry Research
- Vol. 361, 117168
Placental mitochondrial DNA variants, copy number and telomere length alterations in relation to antenatal depressive symptoms
- 28 January 2026
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (6) , 1418-1422
Expanding the Phenotype of STAMBP ‐Related Microcephaly‐Capillary Malformation Syndrome
Biallelic variants in the STAMBP gene are known to cause Microcephaly‐capillary malformation syndrome (MICCAP syndrome). Here we report an 18‐month‐old female with a novel splice site variant, c.376‐1G>A in intron‐4, with the phenotype of a patient who presented to us with fetal onset growth retardation, developmental delay, drug‐resistant seizures, multiple capillary malformations, dysmorphism, tone abnormalities, and distal skeletal and nail abnormalities. Functional studies by RNA analysis and quantitative polymerase chain reaction (qPCR) showed that the variant leads to loss of function. The clinical features noted in this child strongly overlapped with the phenotypes reported in the literature, except for absent dentition and retinal dystrophy‐like findings on fundus examination. A total of 22 cases have been reported in the literature. We present a detailed description of an Indian child, expanding the clinical and molecular spectrum of STAMBP‐ related disease.
- 28 January 2026
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (6) , 1418-1422
Expanding the Phenotype of STAMBP ‐Related Microcephaly‐Capillary Malformation Syndrome
Biallelic variants in the STAMBP gene are known to cause Microcephaly‐capillary malformation syndrome (MICCAP syndrome). Here we report an 18‐month‐old female with a novel splice site variant, c.376‐1G>A in intron‐4, with the phenotype of a patient who presented to us with fetal onset growth retardation, developmental delay, drug‐resistant seizures, multiple capillary malformations, dysmorphism, tone abnormalities, and distal skeletal and nail abnormalities. Functional studies by RNA analysis and quantitative polymerase chain reaction (qPCR) showed that the variant leads to loss of function. The clinical features noted in this child strongly overlapped with the phenotypes reported in the literature, except for absent dentition and retinal dystrophy‐like findings on fundus examination. A total of 22 cases have been reported in the literature. We present a detailed description of an Indian child, expanding the clinical and molecular spectrum of STAMBP‐ related disease.
- Open Access
- 4 November 2024
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 14 (1) , 54
Adult-Onset Neuronal Ceroid Lipofuscinosis: CLN5 Variant Presenting as Focal Dystonia
Tremor and Other Hyperkinetic Movements (TOHM) [ISSN: 2160-8288], a fully open access peer-reviewed journal, publishes clinical and scientific papers on tremor and hyperkinetic movements. TOHM is indexed in PubMed and PubMed Central. In contrast to other publications focusing on disorders of hypokinesia (i.e., mainly Parkinson’s disease), TOHM emphasizes the hyperkinetic movements, giving center stage to clinical observations and research in this area. Papers on Parkinson’s disease and related disorders will be considered if they relate to the hyperkinetic features of these diseases (e.g., tremor, dystonia, dyskinesias). The average turnaround time from submission to first decision is roughly 24 days (~3.5 weeks). The average turnaround time from acceptance to publication is 18 days (~2.5 weeks) with a median of 14 days (2 weeks). Tremor and Other Hyperkinetic Movements is indexed with the Web of Science Emerging Sources Citation Index. As of 2024, Tremor has a Journal Impact Factor of 2.5.
- 4 November 2024
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 14 (1) , 54
Open AccessAdult-Onset Neuronal Ceroid Lipofuscinosis: CLN5 Variant Presenting as Focal Dystonia
Tremor and Other Hyperkinetic Movements (TOHM) [ISSN: 2160-8288], a fully open access peer-reviewed journal, publishes clinical and scientific papers on tremor and hyperkinetic movements. TOHM is indexed in PubMed and PubMed Central. In contrast to other publications focusing on disorders of hypokinesia (i.e., mainly Parkinson’s disease), TOHM emphasizes the hyperkinetic movements, giving center stage to clinical observations and research in this area. Papers on Parkinson’s disease and related disorders will be considered if they relate to the hyperkinetic features of these diseases (e.g., tremor, dystonia, dyskinesias). The average turnaround time from submission to first decision is roughly 24 days (~3.5 weeks). The average turnaround time from acceptance to publication is 18 days (~2.5 weeks) with a median of 14 days (2 weeks). Tremor and Other Hyperkinetic Movements is indexed with the Web of Science Emerging Sources Citation Index. As of 2024, Tremor has a Journal Impact Factor of 2.5.
- 1 July 2024
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (11) , e63809
A unique case of hyperammonemia due to CA5A deficiency: Impact of coexisting gene mutations, pseudogene, and microdeletion
Carbonic anhydrase 5A (CA5A) belongs to a family of carbonic anhydrases which are zinc metalloenzymes involved in the reversible hydration of CO2 to bicarbonate. Mutations in CA5A are very rare and known to cause Carbonic anhydrase 5A deficiency (CA5AD), an autosomal recessive inborn error of metabolism characterized clinically by acute onset of encephalopathy in infancy or early childhood. CA5A also has two very identical pseudogenes whose interference may result in compromised accuracy in targeted sequencing. We report a unique case of CA5AD caused by compound heterozygous variant (NM_001739.2: c.721G>A: p.Glu241Lys & NM_001739.2: c.619‐3420_c.774 + 502del4078bp) in an infant in order to expand the phenotypic spectrum and underscore the impact of pseudogenes, which can introduce complexities in molecular genetic analysis.
- 1 July 2024
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (11) , e63809
A unique case of hyperammonemia due to CA5A deficiency: Impact of coexisting gene mutations, pseudogene, and microdeletion
Carbonic anhydrase 5A (CA5A) belongs to a family of carbonic anhydrases which are zinc metalloenzymes involved in the reversible hydration of CO2 to bicarbonate. Mutations in CA5A are very rare and known to cause Carbonic anhydrase 5A deficiency (CA5AD), an autosomal recessive inborn error of metabolism characterized clinically by acute onset of encephalopathy in infancy or early childhood. CA5A also has two very identical pseudogenes whose interference may result in compromised accuracy in targeted sequencing. We report a unique case of CA5AD caused by compound heterozygous variant (NM_001739.2: c.721G>A: p.Glu241Lys & NM_001739.2: c.619‐3420_c.774 + 502del4078bp) in an infant in order to expand the phenotypic spectrum and underscore the impact of pseudogenes, which can introduce complexities in molecular genetic analysis.
- 28 February 2024
- Published by Elsevier in Mitochondrion
- Vol. 76, 101853
Mitochondria in biology and medicine – 2023
- 28 February 2024
- Published by Elsevier in Mitochondrion
- Vol. 76, 101853
Mitochondria in biology and medicine – 2023
- 2 September 2021
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 49 (5) , 708-712
Leukodystrophy Due to eIF2B Mutations in Adults
Vanishing white matter disease (VWMD) due to eIF2B mutations is a common leukodystrophy characterised by childhood onset, autosomal recessive inheritance, and progressive clinical course with episodic worsening. There are no reports of genetically confirmed adult patients from India. We describe the phenotype of two adults with genetically confirmed VWMD and typical radiological findings. Both had spastic ataxia and cognitive and behavioural disturbances. Other neurological features included myoclonic jerks and parkinsonism. At the last follow-up (duration: 2–9 years), one patient was wheelchair-bound. VWMD is rare in adults but should be suspected based on radiological findings and confirmed by eIF2B mutation.
- 2 September 2021
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 49 (5) , 708-712
Leukodystrophy Due to eIF2B Mutations in Adults
Vanishing white matter disease (VWMD) due to eIF2B mutations is a common leukodystrophy characterised by childhood onset, autosomal recessive inheritance, and progressive clinical course with episodic worsening. There are no reports of genetically confirmed adult patients from India. We describe the phenotype of two adults with genetically confirmed VWMD and typical radiological findings. Both had spastic ataxia and cognitive and behavioural disturbances. Other neurological features included myoclonic jerks and parkinsonism. At the last follow-up (duration: 2–9 years), one patient was wheelchair-bound. VWMD is rare in adults but should be suspected based on radiological findings and confirmed by eIF2B mutation.
- 1 September 2021
- Published by Elsevier in Mitochondrion
- Vol. 60, 170-177
Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders
- 1 September 2021
- Published by Elsevier in Mitochondrion
- Vol. 60, 170-177
Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders
- 6 July 2021
- Published by Wolters Kluwer Health in Neurology
- Vol. 97 (1) , 40-43
Child Neurology: Hereditary Folate Malabsorption
- 6 July 2021
- Published by Wolters Kluwer Health in Neurology
- Vol. 97 (1) , 40-43
Child Neurology: Hereditary Folate Malabsorption
- 1 May 2021
- Published by Elsevier in Mitochondrion
- Vol. 58, 64-71
Ethylmalonic encephalopathy ETHE1 p. D165H mutation alters the mitochondrial function in human skeletal muscle proteome
- 1 May 2021
- Published by Elsevier in Mitochondrion
- Vol. 58, 64-71
Ethylmalonic encephalopathy ETHE1 p. D165H mutation alters the mitochondrial function in human skeletal muscle proteome
- 1 November 2020
- Published by Elsevier in Neurochemistry International
- Vol. 140, 104846
Exposure to the neurotoxin 3-nitropropionic acid in neuronal cells induces unique histone acetylation pattern: Implications for neurodegeneration
- 1 November 2020
- Published by Elsevier in Neurochemistry International
- Vol. 140, 104846
Exposure to the neurotoxin 3-nitropropionic acid in neuronal cells induces unique histone acetylation pattern: Implications for neurodegeneration